CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-16 | Smith Brandon S. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 226,667 | ||
| 2023-08-02 | Zago Wagner M. Chief Scientific Officer | Option exercise 10b5-1 | +4,000 | $12.15 | $49K | 4,000 |
| 2023-08-02 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −3,771 | $66.98 | $253K | 229 |
| 2023-08-02 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −229 | $68.07 | $16K | 0 |
| 2023-08-02 | Zago Wagner M. Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 58,000 | ||
| 2023-08-02 | Karp Carol D. Chief Regulatory Officer | Option exercise 10b5-1 | +5,000 | $12.15 | $61K | 5,000 |
| 2023-08-02 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −4,672 | $66.95 | $313K | 328 |
| 2023-08-02 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −328 | $67.95 | $22K | 0 |
| 2023-08-02 | Karp Carol D. Chief Regulatory Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 55,000 | ||
| 2023-07-26 | Malecek Michael J Chief Legal Officer | Option exercise 10b5-1 | +5,000 | $10.27 | $51K | 5,000 |
| 2023-07-26 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −2,477 | $61.78 | $153K | 2,523 |
| 2023-07-26 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −1,903 | $62.69 | $119K | 620 |
| 2023-07-26 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −620 | $63.40 | $39K | 0 |
| 2023-07-26 | Malecek Michael J Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 100,000 | ||
| 2023-07-19 | Walker Karin L Chief Accounting Officer | Option exercise 10b5-1 | +5,000 | $15.04 | $75K | 5,000 |
| 2023-07-19 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −3,966 | $68.96 | $273K | 1,034 |
| 2023-07-19 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −1,034 | $70.08 | $72K | 0 |
| 2023-07-19 | Walker Karin L Chief Accounting Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 10,481 | ||
| 2023-07-12 | Garren Hideki Chief Medical Officer | Option exercise 10b5-1 | +2,000 | $24.90 | $50K | 2,000 |
| 2023-07-12 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −1,908 | $67.48 | $129K | 92 |
Page 10 of 41 · 819 trades